In addition, no differences between CD4+ or CD8+ T-cell responses were observed across groups, although we reported higher IFN-γ and IL-2 production in HD patients with previous SARS-CoV-2 infection compared to controls at V3+3M. The gene discussed is CD8A; the disease is Huntington disease.